Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 8Not yet recruiting 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Breast Neoplasms 424Neoplasms 281Carcinoma, Non-Small-Cell Lung 272Colorectal Neoplasms 236Prostatic Neoplasms 173Lung Neoplasms 172Carcinoma, Hepatocellular 157Stomach Neoplasms 126Leukemia, Myeloid, Acute 120Pancreatic Neoplasms 118Multiple Myeloma 106Recurrence 99Uterine Cervical Neoplasms 97Squamous Cell Carcinoma of Head and Neck 89Neoplasm Metastasis 88Rectal Neoplasms 87Ovarian Neoplasms 81Triple Negative Breast Neoplasms 77Small Cell Lung Carcinoma 72Head and Neck Neoplasms 69Brain Neoplasms 68Esophageal Neoplasms 65Glioblastoma 64Endometrial Neoplasms 60Colonic Neoplasms 59Melanoma 55Hematologic Neoplasms 53Precursor Cell Lymphoblastic Leukemia-Lymphoma 48Motor Activity 48Carcinoma, Renal Cell 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Interventional × Polyradiculoneuropathy, Chronic Inflammatory Demyelinating × Clear all
NCT06485232 2025-01-01

Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System.

Xuanwu Hospital, Beijing

Phase EARLY_PHASE1 Not yet recruiting
25 enrolled

Multiple Sclerosis, Myasthenia Gravis, Neuromyelitis Optica, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡